Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-014324 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
130,037
Total Value
$158,319.84
P&L
+inf% (+$2,748,487.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Aug 18, 2022 | Grant/Award | 16,750 | $0.00 | $0.00 | 97,401 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Feb 27, 2026 | Grant/Award | 30,000 | $0.00 | $0.00 | 127,401 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 6,106 | $25.16 | $153,629.40 | 121,295 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 181 | $25.91 | $4,690.43 | 121,150 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Medical Officer | Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 77,000 | $0.00 | $0.00 | 77,000 | Direct | โ | View Details |